Mar 14 |
Coherus BioSciences, Inc. (CHRS) Q4 2023 Earnings Call Transcript
|
Mar 13 |
Coherus BioSciences Inc (CHRS) Reports Growth in Net Revenue for Q4 and Full Year 2023 Despite ...
|
Mar 13 |
Coherus BioSciences Non-GAAP EPS of -$0.62 misses by $0.52, revenue of $91.5M beats by $1.07M
|
Mar 13 |
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
|
Mar 13 |
Earnings Scheduled For March 13, 2024
|
Mar 12 |
Coherus BioSciences Q4 2023 Earnings Preview
|
Mar 6 |
In the wake of Coherus BioSciences, Inc.'s (NASDAQ:CHRS) latest US$49m market cap drop, institutional owners may be forced to take severe actions
|
Mar 5 |
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
|
Mar 4 |
Coherus Completes Divestiture of Ophthalmology Franchise
|
Feb 23 |
Coherus BioSciences Announces New Employment Inducement Grants
|